Clinical Study | Office of Clinical Research

Incyte Incb 39110-301 A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Of Itacitinib Or Placebo In Combination With Corticosteroids For The Treatment Of First-Line Acute Graft-Versus-Host Disease

Posted Date: Jun 10, 2019

Investigator: Zartash Gul
Specialties: Cancer, Oncology
Type of Study: Drug

Compare the efficacy of itacitinib in combination with corticosteroids versus placebo in combination with corticosteroids in terms of overall response rate (ORR) at Day 28 in subjects with acute graft-versus-host disease

Criteria:

At Least 18 Years Of Age, Evidence Of Myeloid Engraftment, No Active Uncontrolled Infection, No More Than 1 Allo-Hsct, No Breastfeeding Or Pregnancy.

Keywords:

Cancer, Oncology

For More Information:

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List